Related Experiment Video
Updated: Jun 6, 2026
An Assay to Detect Protection of the Retinal Vasculature from Diabetes-Related Death in Mice
Published on: January 12, 2024
Validation of structural and functional lesions of diabetic retinopathy in mice
T S Kern1, J Tang, B A Berkowitz
1Department of Medicine, Case Western Reserve University, Veterans Affairs Medical Center, Cleveland, OH 44106-4951, USA. tsk@case.edu
Abstract:
Diabetic retinopathy is a serious long-term complication of diabetes mellitus. There is considerable interest in using mouse models, which can be genetically modified, to understand how retinopathy develops and can be inhibited. Not all retinal lesions that develop in diabetic patients have been reproduced in diabetic mice; conversely, not all abnormalities found in diabetic mice have been studied or identified in diabetic patients. Thus, it is important to recognize which structural and functional abnormalities that develop in diabetic mice have been validated against the lesions that characteristically develop in diabetic patients. Those lesions that have been observed to develop in the mouse models to date are predominantly characteristic of the early stages of retinopathy. Identification of new therapeutic ways to inhibit these early lesions is expected to help inhibit progression to more advanced and clinically important stages of retinopathy.
Insights
Diabetic retinopathy research uses mouse models to study disease development. Current models primarily replicate early-stage diabetic retinopathy, highlighting the need for validation against human diabetic eye disease.
Area of Science:
- Ophthalmology
- Diabetology
- Translational Medicine
Background:
- Diabetic retinopathy (DR) is a severe complication of diabetes mellitus.
- Mouse models are crucial for understanding DR pathogenesis and developing inhibitors.
- Existing mouse models do not fully replicate human DR lesions.
Purpose of the Study:
- To assess the validity of mouse models for diabetic retinopathy research.
- To identify which abnormalities in mouse models correspond to human diabetic eye disease.
- To guide the development of therapies targeting early-stage retinopathy.
Main Methods:
- Comparative analysis of retinal lesions in diabetic mouse models and human patients.
- Review of existing literature on validated and unvalidated abnormalities.
- Focus on structural and functional similarities and differences.
Main Results:
- Current mouse models predominantly exhibit early-stage diabetic retinopathy.
- Not all human DR lesions are recapitulated in mouse models.
- Some mouse model abnormalities lack direct human counterparts.
Conclusions:
- Validation of mouse models against human diabetic retinopathy is essential.
- Focusing on early-stage lesions in mouse models may inform therapeutic strategies.
- Further research is needed to improve the translational relevance of mouse models for advanced DR.
